| Tag | Content |
|---|
EnhancerAtlas ID | HS012-15320 |
Organism | Homo sapiens |
Tissue/cell | Caco-2 |
Coordinate | chr19:2164260-2164960 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RREB1 | MA0073.1 | chr19:2164327-2164347 | CCCCAAACCCCCCCAAGCCG | + | 6.06 | | ZNF263 | MA0528.1 | chr19:2164290-2164311 | CCTCCCGGCCTCCCCTCCTCC | - | 6.82 |
|
| | Number of super-enhancer constituents: 9 | ID | Coordinate | Tissue/cell |
| SE_01122 | chr19:2163266-2164926 | Adrenal_Gland | | SE_27063 | chr19:2162254-2166322 | Esophagus | | SE_34517 | chr19:2163165-2172243 | HCT-116 | | SE_45235 | chr19:2164122-2166090 | NHLF | | SE_51032 | chr19:2163245-2165890 | Sigmoid_Colon | | SE_52998 | chr19:2163254-2166024 | Small_Intestine | | SE_57584 | chr19:2163483-2164633 | VACO_503 | | SE_57584 | chr19:2164663-2165344 | VACO_503 | | SE_65616 | chr19:2162124-2174662 | Pancreatic_islets |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CTACGTGAGT GCCGCCCTCC ACCGTCCCTA CCTCCCGGCC TCCCCTCCTC CGCCGCCCCT 60
GGGGACACCC CAAACCCCCC CAAGCCGCGC TCACCGGTCC CCCCTGCGGA ACGGAGACCC 120
TGGACTCCAC TGTCGCTGCT CCACCCCCGT TGCTTCCCGG CCGAGGGCCC CGCGGCTGTT 180
TCCCGCAGGG TGGGAGCCCC GCGCGCCTGG GGTGGGAGCG GGAGCCGGCG CCCCCGAGCC 240
CTACCGCGGT GCCGTTGCCC CCGCCGGGCT GTCCCGGGCG CGGAACGGAA GGGGTAACTC 300
GTGCCGGCCG CGTTTTGACT GGAAGCCCGC CCGCCCGCCC CGCTCGTTCC CGGCGCTGTC 360
AGTGTGTCCG CCGCCTTATT TTTCTTTTTG AGGGCATCCT TTCCTGTCTC CTCTTCTCTT 420
CTTTTTAAAA ATTGGGCGTT TGTCACGCTT TTCCTACTCG GGCACGGCGG GCCCGACCCT 480
GCGAAGGTGG GAGTTAACGT CCCCTTGAGT GGGCGGGAGC GGTCTGACCT TTGGAAATGG 540
GGAATTTTTG TCCCCGTAAT TTTGAGTGGG TATGGGCTGC CCTGGCCCTG GGAAATTAGG 600
CATCTTTGAC CTGTTAATCC TAGTTGGTTG GGGACAGGCT TTATTTATCC TTGGAAATTG 660
GGACTTCTCC CCGATCTTGA GTGGGCAGGA TTGGGCTCAC 700
|
